Sahin et al., Stoll et al., and Moghdateri et al. actually used tTG IgA to screen their JIA patients [18,20,24]; however, some patients may be positive for EmA only (and tTG-IgA negative, at least in the initial stage of disease) [5,31,32] and, therefore, a cross-sectional study where EmA or tTG IgA are not used together may have lost these CD patients, even if they are very few. Here, TGM2 is linked to Cowden disease.